TSS
CLSD

Two Sigma Securities’s Clearside Biomedical CLSD Stock Holding History

Two Sigma Securities’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,394
Closed -$19.2K – 1577
2025
Q1 		$19.2K Sell
1,394
-19
-1% -$273 ﹤0.01% 1107
2024
Q4 		$20.1K Buy
+1,413
New +$23.2K ﹤0.01% 1318
2024
Q3 		– Sell
-1,253
Closed -$24.4K – 2967
2024
Q2 		$24.4K Sell
1,253
-214
-15% -$4.13K ﹤0.01% 2665
2024
Q1 		$33.7K Buy
+1,467
New +$31.6K ﹤0.01% 2617
2023
Q3 		– Sell
-1,048
Closed -$17.6K – 2998
2023
Q2 		$17.6K Buy
+1,048
New +$18K ﹤0.01% 2530
2023
Q1 		– Sell
-738
Closed -$12.4K – 2734
2022
Q4 		$12.4K Buy
+738
New +$13.3K ﹤0.01% 2334
2022
Q2 		– Sell
-1,443
Closed -$50K – 2280
2022
Q1 		$50K Buy
+1,443
New +$43.2K ﹤0.01% 1873
2019
Q3 		– Sell
-1,100
Closed -$16K – 2091
2019
Q2 		$16K Buy
+1,100
New +$19.6K ﹤0.01% 1965

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Securities's CLSD Position: Q2 2025 in Review

Two Sigma Securities sold out of Clearside Biomedical (CLSD) in Q2 2025, closing a stake of 1,394 shares — an estimated $19.2K sold.

Two Sigma Securities first reported a position in CLSD in Q2 2019 and held it in 8 quarters. The position peaked at $50K in Q1 2022. 44 funds tracked by Wall St. Rank hold CLSD as of Q2 2025.

  • Two Sigma Securities reported no remaining Clearside Biomedical position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,394 Clearside Biomedical shares in Q2 2025, an estimated $19.2K.
  • Two Sigma Securities first reported a position in Clearside Biomedical in Q2 2019 and held it in 8 quarters.
  • Two Sigma Securities's Clearside Biomedical position peaked at $50K in Q1 2022.
  • 44 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.